Abstract
Psoriasis is traditionally viewed as a chronic inflammatory skin disease driven by Th1 cellular immune response. Recently, a novel and unique subset of interleukin (IL)-17 producing CD4+ effector T (Th17) cells, which are distinct from Th1 and Th2 cells, have been discovered. It may be crucial in the pathogenesis of various chronic inflammatory diseases that were formerly categorized as Th1-mediated disorders including psoriasis. Th17 cells may play a more important role than Th1 cells in the pathogenesis of psoriasis. This paper presents the significance of Th17 cells in the pathogenesis of psoriasis as well as in the identification of potential targets for the treatment of psoriasis. Key words: Psoriasis; CD4-positive T-lymphocytes
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Dermatology and Venereology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
